These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18980978)

  • 1. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma.
    Lutgendorf SK; Lamkin DM; Jennings NB; Arevalo JM; Penedo F; DeGeest K; Langley RR; Lucci JA; Cole SW; Lubaroff DM; Sood AK
    Clin Cancer Res; 2008 Nov; 14(21):6839-46. PubMed ID: 18980978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stress hormone-mediated invasion of ovarian cancer cells.
    Sood AK; Bhatty R; Kamat AA; Landen CN; Han L; Thaker PH; Li Y; Gershenson DM; Lutgendorf S; Cole SW
    Clin Cancer Res; 2006 Jan; 12(2):369-75. PubMed ID: 16428474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elevated expression of matrix metalloproteinase-9, and fibronectin concentration in recurrent epithelial ovarian cancer].
    Demeter A; Szirmai K; Oláh J; Papp Z; Jeney A
    Orv Hetil; 2004 Aug; 145(31):1617-24. PubMed ID: 15384859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor and social support in patients with ovarian carcinoma.
    Lutgendorf SK; Johnsen EL; Cooper B; Anderson B; Sorosky JI; Buller RE; Sood AK
    Cancer; 2002 Aug; 95(4):808-15. PubMed ID: 12209725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
    Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
    Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine up-regulates the expression of vascular endothelial growth factor, matrix metalloproteinase (MMP)-2, and MMP-9 in nasopharyngeal carcinoma tumor cells.
    Yang EV; Sood AK; Chen M; Li Y; Eubank TD; Marsh CB; Jewell S; Flavahan NA; Morrison C; Yeh PE; Lemeshow S; Glaser R
    Cancer Res; 2006 Nov; 66(21):10357-64. PubMed ID: 17079456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.
    Lutgendorf SK; Cole S; Costanzo E; Bradley S; Coffin J; Jabbari S; Rainwater K; Ritchie JM; Yang M; Sood AK
    Clin Cancer Res; 2003 Oct; 9(12):4514-21. PubMed ID: 14555525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
    Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
    Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells.
    Fishman DA; Bafetti LM; Stack MS
    Invasion Metastasis; 1996; 16(3):150-9. PubMed ID: 9186550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer.
    Rasool M; Malik A; Basit Ashraf MA; Parveen G; Iqbal S; Ali I; Qazi MH; Asif M; Kamran K; Iqbal A; Iram S; Khan SU; Mustafa MZ; Zaheer A; Shaikh R; Choudhry H; Jamal MS
    PLoS One; 2016; 11(11):e0167149. PubMed ID: 27902750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prominent expression of metalloproteinases in early stages of ovarian tumorigenesis.
    Cai KQ; Yang WL; Capo-Chichi CD; Vanderveer L; Wu H; Godwin AK; Xu XX
    Mol Carcinog; 2007 Feb; 46(2):130-43. PubMed ID: 17131304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases and psychosocial factors in acute coronary syndrome patients.
    Fernandez Machulsky N; Gagliardi J; Fabre B; Miksztowicz V; Lombardo M; García Escudero A; Gigena G; Blanco F; Gelpi RJ; Schreier L; Gidron Y; Berg G
    Psychoneuroendocrinology; 2016 Jan; 63():102-8. PubMed ID: 26431804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice.
    Drew AF; Blick TJ; Lafleur MA; Tim EL; Robbie MJ; Rice GE; Quinn MA; Thompson EW
    Gynecol Oncol; 2004 Dec; 95(3):437-48. PubMed ID: 15581944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of stromal metalloproteinase-2 in ovarian adenocarcinoma and its relation to carcinoma progression.
    Torng PL; Mao TL; Chan WY; Huang SC; Lin CT
    Gynecol Oncol; 2004 Feb; 92(2):559-67. PubMed ID: 14766248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer.
    Périgny M; Bairati I; Harvey I; Beauchemin M; Harel F; Plante M; Têtu B
    Am J Clin Pathol; 2008 Feb; 129(2):226-31. PubMed ID: 18208802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of matrix metalloproteinases and related tissue inhibitors in the cyst fluids of ovarian mucinous neoplasms.
    Furuya M; Ishikura H; Kawarada Y; Ogawa Y; Sakuragi N; Fujimoto S; Yoshiki T
    Gynecol Oncol; 2000 Aug; 78(2):106-12. PubMed ID: 10926788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.